CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 16, 2018

Primary Completion Date

May 21, 2018

Study Completion Date

June 4, 2018

Conditions

Central Nervous System Diseases

Interventions

DRUG

Memantine Tab. 10mg

Memantine Tab. 10mg\* 2T/day, QD, PO

DRUG

Memantine Tab. 10mg + Donepezil Tab. 10mg

Memantine Tab. 10mg\* 2T/day + Donepezil Tab. 10mg \* 1T/day, QD, PO

Trial Locations (1)

Chonbuk National University Hospital, Jeonju